The independent medical news service
18-01-2022 | Oncology | News | Article
Reassurance on radiotherapy use prior to ICI initiation
Treatment with immune checkpoint inhibitors within 90 days of radiotherapy does not lead to a “meaningful increase” in rates of serious adverse events, say researchers who conducted a pooled analysis of US FDA registry data.
IV drip_patient's hand/© sippakorn yamkasikorn / iStock / Thinkstock